StockData
XBiotech Inc. logo

XBiotech Inc. (XBIT) stock

XBITNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 8/30
$1.96+0.00 (0.00%)

Close on Nov 13, 2026Market cap $59.76MP/E –Yield –

XBiotech operating margin

Operating margin is operating income as a percentage of revenue.

XBiotech's operating margin for the twelve months ending Sep 30, 2023 was -12361.7%. For fiscal 2022 it was -860.1%, against -136.4% the year before.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2022Dec 31, 2022-860.1%−723.7
FY2021Dec 31, 2021-136.4%−94.8
FY2020Dec 31, 2020-41.5%–

Quarterly operating margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q4 FY2022Dec 31, 2022-2720.7%−2560.8
Q3 FY2022Sep 30, 2022-380.3%−297.7
Q2 FY2022Jun 30, 2022-790.5%−556.1
Q1 FY2022Mar 31, 2022-1569.0%−1495.7
Q4 FY2021Dec 31, 2021-159.8%−66.4
Q3 FY2021Sep 30, 2021-82.6%−38.3
Q2 FY2021Jun 30, 2021-234.4%−192.3
Q1 FY2021Mar 31, 2021-73.3%−56.1
Q4 FY2020Dec 31, 2020-93.4%–
Q3 FY2020Sep 30, 2020-44.3%–
Q2 FY2020Jun 30, 2020-42.0%–
Q1 FY2020Mar 31, 2020-17.1%–

More XBiotech figures

See a number that looks wrong?